Xueshuang Mei,Hongyi Hu,Guohui Nie. MiR-210 regulates cell cycle in nasopharyngealcarcinoma cell line (CNE-1) under hypoxic condition by reducing the expression of cyclin D1. Oncol Transl Med, 2014, 13: 323-327.
MiR-210 regulates cell cycle in nasopharyngealcarcinoma cell line (CNE-1) under hypoxic condition by reducing the expression of cyclin D1
  
View Full Text  View/Add Comment  Download reader
KeyWord:nasopharyngeal carcinoma; miR-210; cyclin D1; cell cycle
Author NameAffiliation
Xueshuang Mei Department of ENT, Peking University Shenzhen Hospital, Shenzhen 518036, China 
Hongyi Hu Department of ENT, Peking University Shenzhen Hospital, Shenzhen 518037, China 
Guohui Nie Department of ENT, Peking University Shenzhen Hospital, Shenzhen 518038, China 
Hits: 6491
Download times: 7387
Abstract:
      Objective: The aim of our study was to determine the underlying mechanism of miR-210 on regulation of the cell cycle in nasopharyngeal carcinoma cell line CNE-1, particularly through regulation of cyclin D1, under hypoxic conditions. Methods: The CNE-1 cell line was induced with hypoxia, and the expression levels of endogenic miR-210 and cyclin D1 were detected by real-time PCR and Western blotting. Next, the luciferase assay was used to confirm that cyclin D1 is a target gene for miR-210. Cell cycle and cell proliferation were detected in CNE-1 cells that were cultured under hypoxic conditions with either overexpression or knockout of miR-210 using flow cytometry and MTT assay, respectively. Results: Hypoxia induced the expression of miR-210, resulting in reduced mRNA and protein levels of cyclin D1 and repression of cyclin D1 in CNE-1 cells. Further analysis indicated that miR-210 directly binded to the 3’UTR of the cyclin D1 gene, thus regulated the expression of cyclin D1. The flow cytometry assay showed that, under hypoxic conditions, miR-210 blocked CNE-1 cells in the G1 phase, and miR-210 also inhibited the proliferation of CNE-1 cells. Conclusion: Under hypoxic conditions, miR-210 directly reduced the expression of cyclin D1, leading to CNE-1 cells blocked in G1 phase.
Close